This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Major capsid protein L1
From Proteopedia
(Difference between revisions)
| Line 17: | Line 17: | ||
Different HPV types are tissue specific, causing different disease presentations. That is why Gardasil targets nine different types of HPV: Types 6, 11, 16, 18, 31, 33, 45, 52, and 58 <ref name="types"/>. In particular, types 16 and 18 can trigger the development and late onset of cervical carcinoma, a cancer typically seen in sexually active females that is asymptomatic for several months and upwards to a decade before ultimately leading to infertility. HPV-6 and HPV-11 can also cause cervical carcinoma but are more renowned for causing condyloma acuminatum along with oral and laryngeal papillomas. HPV-31, HPV-33, HPV-45, HPV-52, and HPV-58 are all less common causative agents of cervical intraepithelial neoplasia and cancer <ref name="Murray"/>. | Different HPV types are tissue specific, causing different disease presentations. That is why Gardasil targets nine different types of HPV: Types 6, 11, 16, 18, 31, 33, 45, 52, and 58 <ref name="types"/>. In particular, types 16 and 18 can trigger the development and late onset of cervical carcinoma, a cancer typically seen in sexually active females that is asymptomatic for several months and upwards to a decade before ultimately leading to infertility. HPV-6 and HPV-11 can also cause cervical carcinoma but are more renowned for causing condyloma acuminatum along with oral and laryngeal papillomas. HPV-31, HPV-33, HPV-45, HPV-52, and HPV-58 are all less common causative agents of cervical intraepithelial neoplasia and cancer <ref name="Murray"/>. | ||
| - | |||
| - | . | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 19:19, 16 November 2016
| |||||||||||
References
- ↑ 1.0 1.1 Zhai L, Tumban E. Gardasil-9: A global survey of projected efficacy. Antiviral Res. 2016 Jun;130:101-9. doi: 10.1016/j.antiviral.2016.03.016. Epub, 2016 Apr 1. PMID:27040313 doi:http://dx.doi.org/10.1016/j.antiviral.2016.03.016
- ↑ https://www.gardasil9.com
- ↑ 3.0 3.1 http://www.hpvvaccine.org.au/the-hpv-vaccine/how-does-it-work.aspx
- ↑ 4.0 4.1 https://www.medicines.org.uk/emc/medicine/19016
- ↑ Harper DM, Vierthaler SL, Santee JA. Review of Gardasil. J Vaccines Vaccin. 2010 Nov 23;1(107). pii: 1000107. PMID:23805398 doi:http://dx.doi.org/10.4172/2157-7560.1000107
- ↑ http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000703/WC500021140.pdf
- ↑ doi: https://dx.doi.org/10.1128/JVI.77.8.4818-4826.2003
- ↑ http://dx.doi.org/10.1016/j.virol.2013.05.038
- ↑ http://www.uniprot.org/uniprot/P03101
- ↑ https://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_ppi.pdf
- ↑ doi: https://dx.doi.org/10.4161/hv.3.4.4309
- ↑ http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/ucm096052.htm
- ↑ 13.0 13.1 13.2 Murray, Patrick R., Ken S. Rosenthal, and Michael A. Pfaller. "Papillomavirus and Polyomavirus." Medical Microbiology. Philadelphia: Elsevier/Saunders, 2013. 445-450.
Proteopedia Page Contributors and Editors (what is this?)
Morgan Smith, Michal Harel, Jessica Troutman., Maximillia Jackson., Jaime Prilusky

